Who is speaking

Our speaker programmes are carefully researched each year to ensure that delegates are exposed to the highest level of expertise. However, delegates not only benefit from the experience of our speakers, but also gain an insight into the experiences of other attendees – Q&A sessions and panel discussions are utilised to enable sharing of knowledge and facilitate idea exchange.

If you have a cutting edge case study or a presentation and would like to join the speaker panel at one of our events, please contact Jenny Clark at j.clark@oxfordglobal.co.uk

2015 Speakers

  • Yasmina Abdiche
    Research Fellow, Pfizer
  • Dina Anderson
    Senior Principal Scientist, Syntaxin
  • Caroline Barelle
    Research Director, Aberdeen University
  • Andreas Baumann
    Director and Principal Scientific Expert Biologics, Bayer
  • Judith Baumeister
    Senior Director Pharmacology, Ablynx
  • Stanislas Blein
    Director and Head Antibody Engineering, Biologics Research, Glenmark Pharmaceuticals
  • Daryl Drummond
    Vice President, Discovery, Merrimack Pharmaceuticals
  • Jacques Dumas
    Jacques Dumas, Head, Protein Biotherapeutics, Sanofi
  • James Errey
    Director, Biomolecular Structure, Heptares Therapeutics
  • Jonny Finlay
    Director, Protein Discovery and Optimisation, Pfizer
  • Nicolas Fischer
    Head of Research, NovImmune
  • Ernesto Friere
    Professor, John Hopkins University
  • Stefan Geschwindner
    Principal Scientist, AstraZeneca
  • Steffen Hartmann
    Global Head Protein Developability, Novartis
  • Alistair Henry
    Director, Structural Biology and Biophysics, UCB
  • Guy Hermans
    Research Fellow, Ablynx
  • Rob Howes
    Associate Director, HTS, Antibody Discovery and Protein Engineering, MedImmune
  • John Kawooya
    Director, Biologics Optimization, Discovery Research, Amgen
  • Roman Kischel
    Principal Scientist, Amgen
  • Will Lewis
    Head of Purification Research, GSK
  • Laura Lin
    Director, Biophysics, Analytics and Bioconjugation, Pfizer
  • Lorenz Mayr
    Vice President, Global Head Reagents and Assay Development, AstraZeneca
  • Mark McAlistair
    Director (Acting), Protein Structure & Biophysics, AstraZeneca
  • Brian McGuinness
    VP Discovery, Crescendo Biologics
  • Werner Meier
    Vice President, Biologics Drug Discovery, Biogen Idec
  • Muthu Meiyappan
    Associate Director, Head of Analytical, Discovery Therapeutics, Shire
  • Ralph Minter
    Fellow, Antibody Discovery and Protein Engineering, MedImmune
  • Herbert Nar
    Director, Structural Research, Boehringer Ingelheim
  • Jennifer Nemeth
    Associate Director, Biologics Discovery Program Leader, Janssen Research and Development
  • Ray Owens
    Professor, Oxford University and Head, OPPF-UK
  • Renuka Pillutla
    Associate Director, Bioanalytical Sciences, Bristol-Myers Squibb
  • Andrew Popplewell
    Director, V-Region Discovery and Engineering, UCB
  • Matthew Sleeman
    Senior Director of Biology, Respiratory, Inflammation and Autoimmunity, MedImmune
  • Crystal Sung
    Scientific Director, Sanofi
  • Marco Thomann
    Manager, Development Analytics, Roche
  • Annelise Vuidepot
    Head of Protein Science, Immunocore
  • Robert Wilkinson
    Director, Oncology, MedImmune
  • Stefan Zahn
    Principal Scientist, Novo Nordisk
test2_sp_probiopeptest1_sp_probiopeptest4_del_probiopeptest3_sp_probiopeptest7_del_probiopeptest6_del_probiopep